Crinetics Pharmaceuticals, Inc. (CRNX) financial statements (2022 and earlier)

Company profile

Business Address 10222 BARNES CANYON ROAD, BLDG. #2
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:333,700170,900118,400163,900
Cash and cash equivalents200,69593,08740,32644,973
Short-term investments133,01277,79378,066118,902
Other undisclosed cash, cash equivalents, and short-term investments(7)20825
Receivables1,052113449568
Prepaid expense888693  
Other current assets9121,0241,0911,224
Other undisclosed current assets8,1684,7623,399991
Total current assets:344,720177,492123,339166,683
Noncurrent Assets
Operating lease, right-of-use asset1,8922,2322,510
Property, plant and equipment2,8253,1813,9464,232
Restricted cash and investments500500500500
Other noncurrent assets 4082 
Other undisclosed noncurrent assets1,078   
Total noncurrent assets:6,2955,9537,0384,732
TOTAL ASSETS:351,015183,445130,377171,415
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8,4685,5885,4987,925
Accounts payable   1,456
Accrued liabilities   4,190
Employee-related liabilities   2,279
Other undisclosed accounts payable and accrued liabilities8,4685,5885,498 
Debt  724 
Other liabilities939835724 
Other undisclosed current liabilities6,5884,0661,394 
Total current liabilities:15,99510,4898,3407,925
Noncurrent Liabilities
Long-term debt and lease obligation3,0744,0144,849 
Operating lease, liability3,0744,0144,849
Liabilities, other than long-term debt223493,265
Deferred compensation liability, classified22349202
Deferred rent credit   3,063
Total noncurrent liabilities:3,0764,0374,8983,265
Total liabilities:19,07114,52613,23811,190
Stockholders' equity
Stockholders' equity attributable to parent, including:331,944168,919117,139160,225
Common stock   24
Additional paid in capital   203,520
Accumulated other comprehensive income (loss)(382)2514861
Accumulated deficit(275,255)(167,614)(93,802)(43,380)
Other undisclosed stockholders' equity attributable to parent607,581336,508210,793 
Total stockholders' equity:331,944168,919117,139160,225
TOTAL LIABILITIES AND EQUITY:351,015183,445130,377171,415

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues1,078711,1932,428
Gain on disposition of assets for financial service operations2,000   
Gross profit:1,078711,1932,428
Operating expenses(108,780)(75,024)(55,025)(31,138)
Operating loss:(107,702)(74,953)(53,832)(28,710)
Nonoperating income611,1413,4101,595
Investment income, nonoperating1579913,4601,748
Net loss available to common stockholders, diluted:(107,641)(73,812)(50,422)(27,115)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(107,641)(73,812)(50,422)(27,115)
Other comprehensive income (loss)(407)(123)8761
Comprehensive loss, net of tax, attributable to parent:(108,048)(73,935)(50,335)(27,054)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: